Total reported value
$72.4M
Reporting period: 2025-12-31 · Number of holdings: 3
MWG Caph Ltd disclosed 3 holdings in its latest 13F filing for the period ending 2025-12-31, with total reported value of $72.4M and a quarterly turnover rate of 0.0%.
Browse other institutions with under $100M AUMBrowse other institutions starting with "M"
No holding changes this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | BEAM | Beam Therapeutics INC | Stock-Other | 48.53% | — | — | — |
| 2 | LYEL | Lyell Immunopharma INC | Stock-Other | 42.88% | — | — | — |
| 3 | PRME | Prime Medicine INC | Stock-Other | 8.59% | — | — | — |
Performance for Q3 2026
-16.6%
Performance Last 4 Quarters
-21.3%
Based on 5 months of available history
Not enough data yet to compute personality scores
Not enough sector-mapped data yet
Not enough sector-mapped data yet
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|
Institutions with a similar AUM
CIK 0001425362
Total reported value
$72.3M
9 stks
2014-09-30
Stale — no recent filing
AUM within 0.1% of this institution
CIK 0001926723
Total reported value
$72.5M
79 stks
2022-12-31
Stale — no recent filing
AUM within 0.1% of this institution
CIK 0001027799
Total reported value
$72.2M
75 stks
2018-03-31
Stale — no recent filing
AUM within 0.2% of this institution
Institutions with overlapping top holdings
CIK 0001845151
Total reported value
$81.3M
3 stks
2025-09-30
Stale — no recent filing
3 of the top 5 holdings overlap, including Beam Therapeutics INC
CIK 0001274403
Total reported value
$677.1M
10 stks
2026-03-31
1 of the top 5 holdings overlap, including Beam Therapeutics INC
CIK 0001550093
Total reported value
$266.8M
10 stks
2026-03-31
1 of the top 5 holdings overlap, including Lyell Immunopharma INC